Synthesis, DFT Calculation, and Antimicrobial Studies of Novel Zn(II), Co(II), Cu(II), and Mn(II) Heteroleptic Complexes Containing Benzoylacetone and Dithiocarbamate

Table 3

Summary of antimicrobial screening of the mixed ligand complexes.

Name	S. aureus	S. pneumoniae	E. coli	A. candida	Aspergillus niger
CoLL′	16.3 ± 0	12.0 ± 0.1	19.0 ± 0.2	11.0 ± 0.1	10.0 ± 0.03
MnLL′	R	R	8.0 ± 0.4	5.2 ± 0.7	13.0 ± 0.7
CuLL′	13.0 ± 0.01	18.0 ± 0.1	15.0 ± 0.3	20.1 ± 0.02	15.3 ± 0.01
ZnLL′	11.5 ± 0.03	13.0 ± 1.4	20.2 ± 0.12	16.0 ± 0	18.0 ± 0.1
Streptomycin	23.2 ± 0.1	23.2 ± 0.03	25.1 ± 0	—	—
Fluconazole	—	—	—	24.0 ± 0.1	25.0 ± 0
DMSO	R	R	R	R	R